XML 19 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenues:    
Revenues $ 4,823 $ 5,887
Expenses    
Cost of product sales 1,399
Research and development 29,867 27,493
Selling, general and administrative 15,865 6,238
Royalty 69 87
Total operating expenses 45,801 35,217
Loss from operations (40,978) (29,330)
Interest and other income 6,446 596
Interest expense (3,047) (2,726)
(Loss) gain on foreign currency derivative (20) 406
Net loss (37,599) (31,054)
Unrealized (loss) gain on available for sale investments (25) 208
Net comprehensive loss $ (37,624) $ (30,846)
Basic and diluted net loss per common share (in dollars per share) $ (0.24) $ (0.28)
Weighted average shares outstanding (in shares) 154,156 110,167
Product [Member]    
Revenues:    
Revenues $ 218 $ 1,679
Royalty [Member]    
Revenues:    
Revenues 1,945 2,322
Collaborative and Other Research and Development [Member]    
Revenues:    
Revenues $ 2,660 $ 1,886